Cryo Cell International Inc financial data

Symbol
CCEL on NYSE
Industry
Services-Misc Health & Allied Services, NEC
Location
700 Brooker Creek Blvd, Suite 1800, Oldsmar, FL
State of incorporation
DE
Fiscal year end
November 30
Latest financial report
10-Q - Q2 2024 - Jul 15, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 49.8 % -2.33%
Quick Ratio 4.21 % -2.99%
Debt-to-equity -895 % +82.1%
Return On Equity 116 %
Return On Assets -14.6 % -524%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.06M shares -2.73%
Common Stock, Shares, Outstanding 8.06M shares -2.7%
Entity Public Float 27M USD -23.8%
Common Stock, Value, Issued 148K USD +0.01%
Weighted Average Number of Shares Outstanding, Basic 8.12M shares -2.49%
Weighted Average Number of Shares Outstanding, Diluted 8.23M shares -1.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 1.53M USD +184%
Costs and Expenses 44.4M USD +64.8%
Operating Income (Loss) -12.8M USD -414%
Nonoperating Income (Expense) 144K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -12.7M USD -548%
Income Tax Expense (Benefit) -3.36M USD -732%
Net Income (Loss) Attributable to Parent -9.3M USD -506%
Earnings Per Share, Basic -1.11 USD/shares -511%
Earnings Per Share, Diluted -1.11 USD/shares -496%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 469K USD -58.3%
Marketable Securities, Current 1.06M USD +86.6%
Accounts Receivable, after Allowance for Credit Loss, Current 6.83M USD +2.23%
Inventory, Net 708K USD -19.5%
Other Assets, Current 435K USD +6.46%
Assets, Current 10.2M USD -1.52%
Deferred Income Tax Assets, Net 20.5M USD +49.1%
Property, Plant and Equipment, Net 22.2M USD +29.6%
Operating Lease, Right-of-Use Asset 882K USD -25.8%
Intangible Assets, Net (Excluding Goodwill) 955K USD -32.5%
Goodwill 1.94M USD 0%
Other Assets, Noncurrent 30.2M USD -26.8%
Assets 62.6M USD -9%
Accounts Payable, Current 1.83M USD -54.9%
Accrued Liabilities, Current 3.22M USD +45.1%
Contract with Customer, Liability, Current 9.58M USD +1.32%
Liabilities, Current 19.4M USD -1.32%
Contract with Customer, Liability, Noncurrent 43.9M USD +13.6%
Operating Lease, Liability, Noncurrent 672K USD -30.5%
Other Liabilities, Noncurrent 53.9M USD +7.92%
Liabilities 73.3M USD +5.3%
Retained Earnings (Accumulated Deficit) -29.9M USD -45%
Stockholders' Equity Attributable to Parent -10.7M USD -1151%
Liabilities and Equity 62.6M USD -9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -357K USD -122%
Net Cash Provided by (Used in) Financing Activities 539K USD
Net Cash Provided by (Used in) Investing Activities -341K USD +71.6%
Common Stock, Shares Authorized 20M shares 0%
Common Stock, Shares, Issued 14.8M shares +0.01%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Interest Paid, Excluding Capitalized Interest, Operating Activities 444K USD +0.57%
Deferred Tax Assets, Valuation Allowance 1.52M USD +0.4%
Deferred Tax Assets, Gross 23.6M USD +44%
Operating Lease, Liability 967K USD -18.9%
Payments to Acquire Property, Plant, and Equipment 458K USD +21.9%
Property, Plant and Equipment, Gross 29.1M USD +36.1%
Operating Lease, Liability, Current 295K USD +31.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 458K USD +5.06%
Lessee, Operating Lease, Liability, to be Paid, Year One 436K USD +42.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 119K USD -40.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 38.2K USD -91.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 500K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 38.2K USD
Operating Lease, Payments 331K USD -4.68%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 82K USD -14.6%
Depreciation, Depletion and Amortization 86K USD -76.7%
Share-based Payment Arrangement, Expense 832K USD +6.39%
Interest Expense 886K USD -52.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%